![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LAM IPM WOUND GEL RECEIVES REGULATORY APPROVAL FOR PANAMA
LAM IPM WOUND GEL RECEIVES REGULATORY APPROVAL FOR PANAMA
LAM Pharmaceutical, Corp. (OTC: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that it received a regulatory approval to market and sell its patented and proprietary LAM IPM Wound Gel(TM) in the Republic of Panama. The approval was granted Ministerio de Salud, Direccion Nacional de Farmacia y Drogas (the Panamanian Ministry of Health), registration number "61523".
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-14-2005/0004107011&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct